TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
9.03
-0.14 (-1.53%)
Sep 8, 2026, 12:48 PM CST

TPEX:4157 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
155.11145.0974.14374.66243.11364.93
Short-Term Investments
692.6674.82751.28598.2591.11495.38
Trading Asset Securities
67.56206.84194.465.1464.3964.09
Cash & Short-Term Investments
915.271,0271,0201,038898.6924.4
Cash Growth
0.14%0.68%-1.75%15.51%-2.79%179.46%
Accounts Receivable
9.435.017.338.9818.41278.28
Other Receivables
4.947.939.0724.885.32.61
Receivables
14.3712.9416.433.8723.71280.89
Inventory
70.2376.142.7134.1515.3517.88
Other Current Assets
2.614.157.164.3711.578.84
Total Current Assets
1,0021,1201,0861,110949.241,232
Property, Plant & Equipment
13.9117.3167.4790.6156.680.43
Long-Term Investments
0.473.412.459.7123.9853.9
Other Intangible Assets
39.622.4512.0512.990.230.16
Other Long-Term Assets
3.594.156.226.1616.9626.31
Total Assets
1,0601,1671,1741,2301,0471,393

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt
-35--3-
Current Portion of Leases
5.665.616.3315.9818.3417.99
Current Income Taxes Payable
--0.11-3.0727.86
Current Unearned Revenue
6.470.150.150.150.150.18
Other Current Liabilities
19.3642.3629.531.7626.7643.85
Total Current Liabilities
31.4983.1146.0847.8951.3289.88
Long-Term Leases
5.788.6242.3958.7117.1335.47
Long-Term Unearned Revenue
-0.030.180.330.480.62
Pension & Post-Retirement Benefits
0.570.633.314.018.0513.15
Total Liabilities
37.8492.3891.96110.9476.98139.11

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
20.7720.7720.9420.9420.9120.91
Additional Paid-In Capital
452.67451.17466.3444.61450.26455.25
Retained Earnings
598.72634.32640.6678.68542.05778.3
Comprehensive Income & Other
-49.95-31.38-45.51-25.34-43.2-0.77
Shareholders' Equity
1,0221,0751,0821,119970.031,254
Total Liabilities & Equity
1,0601,1671,1741,2301,0471,393

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
11.4349.2258.7174.6938.4753.46
Net Cash (Debt)
903.84977.54961.11963.3860.13870.94
Net Cash Growth
9.11%1.71%-0.23%12.00%-1.24%177.67%
Net Cash Per Share
1.281.371.341.341.201.21
Filing Date Shares Outstanding
709.37711.83717.84717.84716.84716.84
Total Common Shares Outstanding
709.37711.83717.84717.84716.84716.84
Working Capital
9711,0371,0401,062897.921,142
Book Value Per Share
1.441.511.511.561.351.75
Tangible Book Value
982.611,0521,0701,106969.81,254
Tangible Book Value Per Share
1.391.481.491.541.351.75
Machinery
-25.54144.93144.38143.76140.92
Leasehold Improvements
-1.7960.7960.6660.7160.67